Corrigendum to “Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation” [Eur J Cancer 57 (April 2016) 118–126] - Aix-Marseille Université Access content directly
Journal Articles European Journal of Cancer Year : 2016

Corrigendum to “Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation” [Eur J Cancer 57 (April 2016) 118–126]

Gilles Houvenaeghel

Domains

Cancer
No file

Dates and versions

hal-03623727 , version 1 (29-03-2022)

Identifiers

Cite

Laurys Boudin, Christian Chabannon, Patrick Sfumato, Renaud Sabatier, François Bertucci, et al.. Corrigendum to “Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation” [Eur J Cancer 57 (April 2016) 118–126]. European Journal of Cancer, 2016, 67, pp.223. ⟨10.1016/j.ejca.2016.09.002⟩. ⟨hal-03623727⟩

Collections

CNRS UNIV-AMU CRCM
8 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More